At a glance
- Originator Ipsen
- Class Anti-inflammatories; Antiallergics; Antiasthmatics
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Inflammation
Most Recent Events
- 17 Mar 1997 Discontinued-Preclinical for Inflammation (Unknown route)